Pediatric urolithiasis: experience at a tertiary care pediatric hospital.
OBJECTIVE
We aimed to determine the epidemiology, risk factors, clinical characteristics, evaluation and course of patients with urolithiasis at the Children's Hospital of Eastern Ontario to improve current diagnostic and management strategies.


METHODS
This was a retrospective study of children with newly identified urolithiasis between Jan. 1, 1999, and July 31, 2004. Cases were reviewed for demographics, presentation, family history, diagnostic methods and findings, metabolic and anatomic abnormalities, management, stone analysis and stone recurrence.


RESULTS
Seventy-two patients (40 male, 32 female; mean age 11.3 yr) were assessed. Mean follow-up was at 1.5 years. Eighteen patients (25%) had a family history of stones. Flank pain (63%) was the most common presentation. Eighty-two percent of urinalyses showed microscopic hematuria. Imaging comprised abdominal plain film radiography (56%) and (or) abdominal ultrasonography (74%). The mean stone size was 5 mm. Forty-one percent (28/69) of patients who underwent metabolic investigation had an abnormality. Fourteen percent of patients (10/72) had a genitourinary anatomical abnormality. Thirty-four patients (47%) passed their stones spontaneously, 25 patients (35%) required surgical intervention and 13 patients (18%) had yet to pass their stone. The mean size of spontaneously passed stones was 4 mm. Of 42 stones analyzed, 39 (93%) were composed of calcium oxalate or phosphate. Seventeen (24%) patients had stone recurrence during follow-up.


CONCLUSIONS
Pediatric patients with stones present in a manner similar to adults. Abdominal plain film radiography and ultrasonography are the preferred initial radiological investigations in children as they limit radiation exposure. Metabolic abnormalities are common and may coexist with anatomic abnormalities, therefore investigations must rule these out. One-half of patients will pass their stones spontaneously. Recurrence rates are high and long-term follow-up is recommended.
Kit
Laura Chang
LC
Pediatric Urology.
Filler
Guido
G
Pike
John
J
Leonard
Michael P
MP
J Urol. 2002 Feb;167(2 Pt 1):670-3
11792950
Urol Clin North Am. 1997 Feb;24(1):173-84
9048860
Scand J Urol Nephrol. 2003;37(2):129-33
12745721
Pediatrics. 1980 Jun;65(6):1068-72
7375229
Pediatr Nephrol. 2001 Sep;16(9):728-32
11511987
Int J Urol. 2000 Sep;7(9):330-4
11020057
J Urol. 2002 Dec;168(6):2568-71
12441985
J Urol. 2000 Jul;164(1):162-5
10840454
Pediatr Surg Int. 2000;16(1-2):60-3
10663838
Am J Med Genet A. 2004 Aug 15;129A(1):51-61
15266616
J Urol. 2000 Sep;164(3 Pt 2):1089-93
10958749
J Urol. 2002 Oct;168(4 Pt 1):1522-5
12352448
Mayo Clin Proc. 1993 Mar;68(3):241-8
8474265
Semin Ultrasound CT MR. 2002 Oct;23(5):402-10
12509110
J Urol. 1999 Sep;162(3 Pt 2):1234-7
10458474
Pediatrics. 1991 Apr;87(4):445-50
2011420
Pediatr Nephrol. 1992 Jan;6(1):54-6
1536741
Urology. 1977 Jun;9(6):627-9
883062
Pediatr Clin North Am. 2001 Dec;48(6):1571-85
11732131